Dear Bitruers,
In accordance with our Delisting Guidelines, we are ending support for the following assets on Bitrue:
NVDAB, MUB, AMDB, INTCB, SNDKB, CRCLB, TSLAB, MSTRB, EWYB, SPCXB, SKHYB, DRAMB, SOXLB, SPYB, QQQB
Please note:
If you currently hold these assets on Bitrue, please take note of the following important dates:
- Deposits have been closed. Any further attempts to deposit these assets will result in the assets being irretrievably lost.
- Trading on all pairs will be closed at 07:00 UTC on July 23, 2026. If you have any open orders, we recommend removing them as soon as possible. Any remaining open orders at the time of closure will be automatically removed.
- Withdrawals will remain available until August 21, 2026. After this deadline, withdrawals will be disabled. Holders of NVDAB, MUB, AMDB, INTCB, SNDKB, CRCLB, TSLAB, MSTRB, EWYB, SPCXB, SKHYB, DRAMB, SOXLB, SPYB, QQQB are required to complete withdrawals by the deadline. Once withdrawals are disabled, we will officially terminate all technical support, rendering the assets irretrievable for both users and Bitrue team members.
If you have any questions or require assistance with the withdrawal process, please do not hesitate to reach out to our customer support team.
Thank you for your continued support and trust in Bitrue. We remain committed to providing you with a safe and reliable trading experience.
Thanks for your support!
Find us on
Disclaimer: Bitrue reserves the right in its sole discretion to amend or cancel this announcement at any time and for any reasons without prior notice.
Cryptocurrency markets are highly volatile and can experience rapid price fluctuations. You may lose some or all of your invested capital, and past performance is not indicative of future results. You are solely responsible for your investment decisions and Bitrue is not liable for any losses you may incur. The information provided on this platform and any associated materials are for informational purposes only and should not be considered as financial or investment advice. For more information, see our Terms of Use and Privacy Policy.